Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that Jim Jeffries has joined the association as Senior Vice President for Public Affairs. Jeffries will oversee AdvaMed®’s communications…
WASHINGTON, D.C. – AdvaMedDx®, a division of the Advanced Medical Technology Association® (AdvaMed®) that focuses on the value diagnostics bring to patients’ health and health care, today announced that Phi…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that Pat Fogarty has joined the association as vice president, assistant general counsel and director of civil justice policy. “We’re…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the Trump Administration’s budget proposal to improve Medicare beneficiary access…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on introduction of bipartisan legislation (S. 692) – the Protect Medical Innovation…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the resignation of FDA Commissioner Scott Gottlieb: “We want to thank Dr.…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on introduction of legislation in the U.S. House of Representatives to…
Leading Health Groups Challenge GAO’s Flawed Report on Medicare Lab Billing February 25, 2019 Washington, D.C. – In response to broad and misleading claims in a recent Government Accountability…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Washington, D.C.— AdvaMedDx® has submitted comments on draft legislation, the Verifying Accurate Leading-Edge IVCT Development (VALID) Act, commending Congress for their support of comprehensive, risk-based diagnostics regulatory reform. “An overarching,…